«
Cardiac stem cells from heart disease patients may be harmful: Researchers discover molecular pathway involved in toxic interaction between host cells and immune system.»
Not exact matches
«We concluded that
stem cells used in
cardiac therapy should be drawn
from healthy donors or be better genetically engineered for the patient.»
This image shows an implanted graft of
cardiac cells derived
from human
stem cells (green) meshed and beat with primates» heart
cells (red).
Only
stem cells from healthy donors or genetically engineered
cells should be used in treating
cardiac conditions.»
The day after his disciplinary dismissal
from University of Tokyo for «damaging the university's honor or credibility,» Hisashi Moriguchi maintained in an interview with ScienceInsider that he really did participate in a groundbreaking experiment to treat a heart disease patient with
cardiac muscle
cells derived
from the patient's own induced pluripotent
stem (iPS)
cells.
In lab experiments, the researchers isolated exosomes
from specialized human
cardiac stem cells and found that exosomes alone had the same beneficial effects as
stem cells.
«Growing beating
cardiac tissue
from stem cells: New model for early heart development.»
Researchers at the University of California, Berkeley, in collaboration with scientists at the Gladstone Institutes, have developed a template for growing beating
cardiac tissue
from stem cells, creating a system that could serve as a model for early heart development and a drug - screening tool to make pregnancies safer.
Researchers
from the Gladstone Institutes, in collaboration with scientists at UC Berkeley, have developed a template for growing beating
cardiac tissue
from stem cells, creating a system that could serve as a model for early heart development and a drug - screening tool to make pregnancies safer.
Researchers at Emory and Georgia Tech have developed a method for Cheap Oakleys purifying
cardiac muscle
cells from stem cell cultures using molecular beacons.
Many clinical trials have used bone marrow - derived
cells, and the benefits here appear to come mostly
from the â $ œparacrine» nurse function. A more ambitious approach is to use progenitor - type
cells, which may have to come
from iPS
cells or
cardiac stem cells isolated via biopsy - like procedures.
They acknowledge modest benefit
from hematopoietic
stem cell transplantation in
cardiac disease and ameliorative but noncurative outcomes in autoimmune diseases.
Cardiac repair in guinea pigs with human engineered heart tissue
from induced pluripotent
stem cells.
Stem cells from the bone marrow can develop into
cardiac muscle, as well as liver, brain, nerve, fat and skin tissue.
A strong regenerative ability of
cardiac stem cells derived
from neonatal hearts.
We accept referrals
from physicians as well as inquiries
from patients diagnosed with CAD, and of course welcome calls and questions
from both physicians and patients about
cardiac stem cell therapy and how the treatment is performed.
• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant
cardiac disease; uncontrolled hypertension • Left ventricular ejection fraction (LVEF) < 45 % • Allogeneic
stem cell transplant within 100 days before first dose of study drug • Known history of human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct in primary site or histology
from the cancer evaluated in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1
from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
Researchers find that Insulin - like growth factor / Insulin - mediated induction of mesodermal differentiation aids the production of
cardiac progenitor
cells from embryonic
stem cells towards a strategy to boost
cardiac cell production.
SAN FRANCISCO, CA — Researchers at the University of California, Berkeley, in collaboration with scientists at the Gladstone Institutes, have developed a template for growing beating
cardiac tissue
from stem cells, creating a system that could serve as a model for early heart development and a drug - screening tool to make pregnancies safer.
Cardiomyocytes (CMs) derived
from human pluripotent
stem cells (hPSCs) are considered a most promising option for
cell - based
cardiac repair.
This strip of
cardiac muscle was generated
from embryonic
stem cells that... (Spencer Platt / Getty Images)
Cho and colleagues
from Cedars - Sinai recently published a paper in
Stem Cell Reports describing how the gene SHOX2 can nudge embryonic stem cells into becoming cardiac pacemaker ce
Stem Cell Reports describing how the gene SHOX2 can nudge embryonic
stem cells into becoming cardiac pacemaker ce
stem cells into becoming
cardiac pacemaker
cells.
«Since patients with heart failure are normally elderly, their
cardiac stem cells aren't very healthy,» Sadia Mohsin, one of the study authors and a postdoctoral research scholar at San Diego State University's Heart Institute, explained in a news release
from the American Heart Association (AHA).